U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market

seekingalpha09-14

Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings.Outparcel REIT FrontView REIT filed to raise $100 million, and Chinese on-demand ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467060374?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1299608214/image_1299608214.jpg","is_english":true,"pubTime":"2024-09-14 17:00","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2467060374","market":"fut","top_or_hot":-1,"title":"U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market","media":"seekingalpha","content":"<div>\n<p>Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings.Outparcel REIT FrontView REIT filed to raise $100 million, and Chinese on-demand ...</p>\n\n<a href=\"https://seekingalpha.com/article/4721109-us-ipo-3-biotechs-lead-active-september-ipo-market\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-14 17:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4721109-us-ipo-3-biotechs-lead-active-september-ipo-market><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings.Outparcel REIT FrontView REIT filed to raise $100 million, and Chinese on-demand ...</p>\n\n<a href=\"https://seekingalpha.com/article/4721109-us-ipo-3-biotechs-lead-active-september-ipo-market\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://seekingalpha.com/article/4721109-us-ipo-3-biotechs-lead-active-september-ipo-market","article_id":"2467060374","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1299608214/image_1299608214.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467060374","pubTimestamp":1726304400,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings.Outparcel REIT FrontView REIT filed to raise $100 million, and Chinese on-demand ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4550":"红杉资本持仓","XCH":"XCHG Limited","BK4207":"综合性银行","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU0396314238.USD":"abrdn SICAV I - LATIN AMERICAN EQUITY \"A\" (USD) ACC","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0050427557.USD":"富达拉丁美洲基金","BCAX":"Bicara Therapeutics","KVUE":"Kenvue Inc","BK4183":"个人用品","LU1481012133.USD":"FIDELITY EMERGING MARKETS \"A\" (USDHDG) INC","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","GLXG":"迦里仕人才","FVNNU":"Future Vision II Acquisition Corp.","IPO":"Renaissance IPO ETF","NU":"Nu Holdings Ltd.","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","IPOS":"Renaissance International IPO ETF","MBX":"MBX Biosciences","BK4585":"ETF&股票定投概念","CFA.SI":"NikkoAM-STC Asia REIT","LU0048575426.USD":"FIDELITY EMERGING MARKETS \"A\" INC","FDN":"First Trust Dow Jones Internet I","LU0261950470.USD":"FIDELITY EMERGING MARKETS \"A\" ACC","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","ZBIO":"Zenas BioPharma Inc.","TDTH":"Trident Digital Tech"},"translate_title":"美国IPO每周回顾：3家生物技术公司引领9月IPO市场活跃","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZBIO":1,"BCAX":1,"KVUE":1,"IPOS":1,"IPO":1,"GLXG":1,"FVNNU":1,"MBX":1,"NU":1,"TDTH":1,"XCH":1,"CFA.SI":0.9,"FDN":0.77},"content_text":"Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings.Outparcel REIT FrontView REIT filed to raise $100 million, and Chinese on-demand courier service provider BingEx also filed to raise $100 million.No IPOs are currently scheduled to list in the week ahead, as activity remains somewhat muted in the run-up to the 2024 presidential election.   Olemedia Six IPOs debuted this past week, including three deals of more than $100 million. Seven IPOs submitted initial filings. Immunology biotech Zenas BioPharma (ZBIO) priced its upsized deal at the midpoint to raise $225 million at a $710 million market capitalization. Advancing its lead bifunctional antibody, obexelimab, targeting both CD19 (a popular target in autoimmune disease) and FcyRIIb, the company is pursuing multiple autoimmune indications, chiefly IgG4-related disease (IgG4-RD), which it expects to report Phase 3 data for in 2024. The company will also have readout in multiple sclerosis, warm autoimmune hemolytic anemia, and systemic lupus erythematosus in the next two years. Zenas BioPharma finished up 7%. Metabolic disease biotech MBX Biosciences (MBX) priced its upsized deal at the high end of the range to raise $163 million at a $538 million market cap. The company is advancing its lead candidate, MBX 2109, for the treatment of chronic hypoparathyroidism, which is a condition causing low blood calcium levels which is primarily caused by removal of the parathyroid gland during neck surgery. While the company has not reported any efficacy data from its lead candidate thus far, and has two even earlier-stage candidates (one of which is intended for the treatment of obesity), it believes its peptide technology may allow for less frequent injections and greater efficacy, with data from its lead candidate expected in the 3Q25. MBX BioPharma finished up 48%. Oncology biotech Bicara Therapeutics (BCAX) priced its upsized deal at the high end of the range to raise $315 million at a $1 billion market cap. The company is advancing its lead candidate, ficerafusp alfa, to improve upon the efficacy of existing EGFR inhibitors in multiple cancers by targeting both EGFR and transforming growth factor beta (TGF-ß). Having raised over $350 million of private funding prior its IPO, the company is conducting a Phase 2/3 trial in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), which it expects to report data from in late 4Q24 or early 1Q25, with hopes of continuing the success of its promising Phase 1 data. Bicara Therapeutics finished up 30%.One SPAC, Future Vision II, priced this week, raising $50 million to target TMT in China. One SPAC, Future Vision II (FVNNU), priced this week, raising $50 million to target TMT in China.   7 IPOs During the Week of September 9th, 2024  Issuer Business Deal Size Market Cap at IPO Price vs. Midpoint First Day Return Return at 09/13    MBX Biosciences (MBX) $163M $538M 7% +48% +48%  Phase 2 biotech developing precision peptides for endocrine and metabolic diseases.  Bicara Therapeutics (BCAX) $315M $1,022M 6% +30% +30%  Phase 1 biotech developing a bifunctional antibody to target solid tumors.  XCharge (XCH) $21M $368M -11% +19% +27%  Provides DC fast chargers and related EV technology out of China and Europe.  Galaxy Payroll (GLXG) $7M $71M -20% +11% +11%  Hong Kong-based provider of outsourced payroll and other business services.  Zenas BioPharma (ZBIO) $225M $710M 0% +7% +7%  Phase 3 biotech developing therapies for autoimmune and inflammatory diseases.  Future Vision II Acq. (FVNNU) $50M $65M 0% +0% +0%  Blank check company targeting the TMT industry in the Greater China region.  Trident Digital Tech (TDTH) $9M $323M -44% -23% -26%  Provides business consulting, marketing, and IT services to SMEs in Singapore.  Click to enlarge Seven IPOs submitted initial filings this past week, including two names that filed to raise $100 million. Outparcel REIT FrontView REIT (FVR) filed to raise $100 million, and Chinese on-demand courier service provider BingEx (FLX) also filed to raise $100 million.   7 Filings During the Week of September 9th, 2024  Issuer Business Deal Size Sector Lead Underwriter    Basel Medical (BMGL) $6M Health Care Cathay Securities  Operates two medical clinics in Singapore.  BingEx (FLX) $100M Industrials CICC  Operates a leading on-demand dedicated courier service in China.  Chain Bridge Bancorp (CBNA) $46M Financials Piper Sandler  Provides online banking services primarily to political organizations.  Brillia (BRIA) $11M Consumer Discretionary A.G.P.  Provider of women's lingerie and intimate apparel.  Diginex (DGNX) $11M Technology Dominari Securities  Provides software that enables businesses to collect, analyze, and report ESG data.  Fitness Champs (FCHL) $9M Consumer Discretionary Bancroft Capital  Leading provider of swim lessons in Singapore.  FrontView REIT (FVR) $100M Real Estate Morgan Stanley  Commercial REIT focused on net lease outparcel properties.  Click to enlarge Week Ahead No IPOs are currently scheduled to list in the week ahead, as activity remains somewhat muted in the run-up to the 2024 presidential election. Some sizable issuers on file are eligible to launch their IPOs in the coming week. These include metabolic disease biotech BioAge Labs (BIOA), seizure diagnostic company CeriBell (CBLL), and pre-revenue potash miner Brazil Potash (GRO). Street research is expected for two companies in the week ahead, and two lock-up periods will be expiring. IPO Market Snapshot The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/12/2024, the Renaissance IPO Index was up 11.5% year-to-date, while the S&P 500 was up 18.5%. Renaissance Capital's IPO ETF (IPO) tracks the index, and top ETF holdings include Kenvue (KVUE) and Nu Holdings (NU). The Renaissance International IPO Index was down 6.1% year-to-date, while the ACWX was up 9.1%. Renaissance Capital’s International IPO ETF (IPOS) tracks the index, and top ETF holdings include Barito Renewables Energy and Amman Mineral Internasional.  Original Post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha editors.  Editor's Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"analysis","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467060374"}